End of Year Round-Up (2025)

End of Year Round-Up (2025)

Date:21 December 2025 Content Sections ● Challenging the medicalisation of everyday life ● Holding big corporates to account ● Defending access to natural health products ● Digital health, surveillance and loss of autonomy ● Evidence-based advocacy and public...
EOY messages in an ANH bottle from the team!

EOY messages in an ANH bottle from the team!

Date:18 December 2025 As we move into 2026, the opportunities and challenges facing natural health and individual autonomy are intensifying—but so is public awareness. The ANH team is moving into the new year committed to: Resisting over-medicalisation and regulatory...
The GLP-1 illusion: Rapid weight loss at a price we cannot ignore

The GLP-1 illusion: Rapid weight loss at a price we cannot ignore

Date:18 December 2025 Content Sections ● Introduction ● What is GLP-1 medication and how does it work? ● The underreported risks of GLP-1 medication ● The real problem: Treating symptoms, not root causes ● A healthier way forward to rebuilding, not medicating, health...
ANH News Beat (week 51/2025)

ANH News Beat (week 51/2025)

Date:15 December 2025 Content Sections ● In Brief (click on the links to read more) ● Natural News ● ANH-USA Update ● Free Speech Threats ● Post-covid related In Brief (click on the links to read more) Multiple chemicals damage gut microbiome PFAS laced water harms...
Learn & Journey: ANH events (week 51/2025)

Learn & Journey: ANH events (week 51/2025)

Date:15 December 2025   Event Upcoming Member events ANH Intention Circle – January 2026 Date: Thursday 8th January 2026 Time: 19:00 (7:00 pm) – 20:15 (8:15 pm) GMT Location: Online via Zoom Open to all Pathfinder Members. Click here for zoom link....
ANH News Beat (week 50/2025)

ANH News Beat (week 50/2025)

Date:11 December 2025 Content Sections ● In Brief (click on the links to read more) ● Natural News ● ANH-USA Update ● Free Speech Threats ● Post-covid related In Brief (click on the links to read more) San Francisco sues UPF manufacturers Reformulating UPFs is little...